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ERYTHROMYCIN, 
STUDIES OF ITS MODE OF ACTION 
FRANK STREICHTOFF 
ELi LiLly and Company 
JndianapoliJ, I1tdicma 
Relatively little is known of the mode of action of erythromycin. This 
antibiotic is widely used in the treatment of infectious diseases and has un­
doubtedy prolonged the lives of thousands of people. It would seem ax­
iomatic that more knowledge of the mode of action would serve as a 
foundation for more effective clinical use. 
Although Pittenger et al. (1) and Haight and Finland (2) had tested
 
some organic and inorganic compounds for reversal of the inhibitory action
 
of erythromycin, it seemed profitable to use a more informative method,
 
Such tests have usually been carried out in liquid media using a single con­

centration of the compound in question and one level of the inhibitory sub­

stance. It was felt that by the use of agar plates, seeded with a sensitive
 
organislU, a solution of the test compound could be introduced 00 a filter
 
paper disk. Through diffusion an infinite variety of concentrations of the
 
test substance would be present in concentric zones around the filter paper
 
disk. The antibiotic could be added either in the bacteriostatic threshold con­

centration to the liquid seeded agar medium before pouring the plate, or
 
added on filter paper disks close to the test compound disks on the hardened
 
I agar surface. After incubation the zones of growth or inhibition could be
 
I
 interpreted in terms of reversal or potentiation of the inhibition of erythro­
mycin and toxicity of the test compound.
 Brown and Emerson (3) found that pantothenic acid, beta-alanine and
 
carnosine reversed the inhibitory action of erythromycin towards the gral;is 
strain of Corynebacterium diphtheriae. No confirmation has been made to
'l date by other investigators. It would seem desirable not only to attempt to 
confirm their work but also to look for a similar situation in other organisms. 
It appeared that organisms in which such an effect would be most apparent 
,vould be those which require either pantothenic acid or beta-alanine for 
growth. In this category LactobaciJlus casei and L. arabillOJIIJ require pan­
tothrnic acid for growth and numerous strains of yeast require either pan· 
tothenic acid or beta-alanine. Since erythromycin is used in the treatment of 
diseases caused by DiplofOatls. MlcrocOCCtLJ and StreptoCO(CIIJ, it seemed 
pertinent to use those organisms to test for the reversal by pantothenic acid 
or beta-alanine of the inhibition due to erythromycin. Finally, it seemed de­
sirable to determine whether the resistance of highly resistant strains of Mi· 
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aococrtlJ pyogr:'ll/;,S vaL aUl'ellJ is due to high production of pantothenic acid. 
Many organisms which are resistant to penicillin are resistant by virtue of 
their production of penicillinase, an enzyme capable of destroying penicillin. 
This enzyme has been found to be extracellular and intracellular in nor­
mally resistant organisms and in organisms in which the resistance has de­
veloped (4). As one of the possible mechanisms of resistance to 
erythromycin, it seemed obvious that an attempt should be made to find 
erythromycinase. Haight and Finland (2), using many strains of the highly 
resistant gram-negative organisms, could find no extracellular erythromy­
cinase. Since resistance in staphylococcal infections has become a serious 
problem, it appeared of value to determine the presence or absence of intra­
cellular or extracellular erythromycinase in the two highly resistant strains of 
iY[icl'ococors pyogelleJ' vaL ourem available. 
One possible mode of action of erythromycin would be its interference 
with the functioning of one or more enzymes necessary to the growth or re­
production or action of the sensitive organism. Stone et at. (5) recently re­
ported that staphylococci which were highly resistant to erythromycin in 
vitro were still sensitive when treated in vivo in mice. Since the pathogenicity 
of the staphylococcus is closely associated with coagulase production, one 
explanation for this phenomenon would be an inhibition of coagulase by 
the antibiotic. 
REVIEW OF THE LITERATURE 
Erythromycin has the formula C37HG1N013 with a structure approximat­
ing that shown in Fig. 1 and a molecular weight of 734. It is a base with a pK 
8.6. It is slightly soluble in water and more readily soluble in organic sol­
vents. A pH of less than 4 or higher than 10 is highly destructive (6, 7). 
Degradation studies have led to the identification of large fragments, includ­
ing erythralosamine, C29H49NOg, and c1adenose, CSH160.l (Fig. 1) (7), One 
fraction of erythralosamine is desosamine, CSH liN03 (Fig. 1) (7). A large 
fragment, dihydroerythronolide, CZ1H4l0S, has been described (Fig. 1) (8). 
Erythromycin appears to be a member of a group of antibiotics which in­
cludes: albomycetin (C32H 54N09, mol. wt" 596) (9), amaromycin (10), 
angolamycin (C-J.9-51HS7-9l-N01S, mol. wt., 977-1005) (11), carbomy­
cin (C41H 6,N01G, mol. wt., 830) (12,13), carbomycin B (C.U-42H61-69 
NOlo, moL wt., 814-828) (14), celesticetin (Cz4H3fJ-40NzOlh mol. wt., 
496-500) (15), erythromycin B (C37 H l1N0J2, mol. wt., 721) (16), griseo­
mycin (17), leucomycin (CZ,H4ZN010' mol. wt., 540) (18), methamycin 
(C25H43NOr, mol. wt., 470) (19), narbomycin (C28H-J.7NO.. , mol. wt., 
510) (20), antibiotic PA-105 (21), pikromycin (Cz5H43N07, mol. wt., 
477), (22), rhodomycin (23) and spiromycin (24). 
In general the members of the erythromycin antibiotic group exhlbit 
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has been noted by other investigators. Organisms show Lng moderate to high 
sensitivity to erythromycin include the following genera: BMil/tls, BruceLltl.. 
Clostridium, COfJllebacterillm, DiplococctlJ, H emophiflls, Micrococcus, My­
cobacterium, Neisseria. RickettJia. Streptococcus, Vibrio.. lymphogranuloma 
virus and meningopoeumonitis virus. In general the gram-negative organ-
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a. erythromycin, b. desosamine, c. c1adenose, 
tl. dihydroerythronolide, e. erythralosamine (R is dihydroetyrhronolide 
minus 2H; R' is dihydroeryrhronolide minus 2H,O). 
Similar antibacterial and antiviral spectra. The resemblance of the spectra of 
carbomycin (12), celesticetin (25), erythromycin B (26), griseomycin 
(17), antibiotic PA-I05 (21) and spiromycin (24) to that of erythromycin 
isms, E5cherichitl. Pro/elts. Pselldomollas. Salmol/elltl and Shigella show high 
resistance. There are variations in the degree of effectiveness of the different 
members of this antibiotic family. Carbomycin, for example, is usually less 
effective than erythromycin. There are some marked differences. Amaromy­
cin, for example, inhibits Bmcelttl tlbOrllfs with 1.56 mcg/ml (10) while 
erythromycin does not inhibit the organism with 1000 111cg/ml (17) even 
though it is quite active against other members of the genus (6). 
Cross-resistance has been demonstrated between erythromycin and erythro­
mycin B (27), carbomycin (28), celesticetin (25), griseomycin (17), anti­
biotic PA-I05 (n), and spiromycin (24). Cross-resistance evidence 
suggests that leucomycin is closely related to carbomycin and somewhat less 
closely related to erythromycin (29). 
... 
The chemical structure desosamine has been demonstrated in erythromy­
Cill (7), erythromycin B (16), pikromycin (23) and narbomycin (20). 
Carbomycin and carbomycin B contain the very similar desoxydimethyl 
amino sugar. mycaminose (14). In rhodomycin the order in which the radi­
cals are attached to the desosamine ring has been changed (23). One of the 
radicals attached to the ring structure in desosamine is a dimethyl amine. It is 
interesting to note that albomycin (9), angoJamycin (11), carbomycin (12), 
carbomycin B (14), erythromycin (7), erythromycin B (16), leucomycin 
(18), methamycin (19), narbomycin (20) and pikromycin (22) all have 
but a single nitrogen atom. 
The literature on other members of the erythromycin antibiotic family! 
reviewed here, indicates no mode of action. 
The effect of various inorganic and organic substances on the bacterio­
static action of erythromycin has been investigated. Pittenger et al. (1); 
working with Micrococclis pyogene.r var. tl1lreus in vitro, found that various 
concentrations of Cl-, NO,:-, SO~-, Na+, K+, Mg++, Ca++, Mn++, 
Cu++, Co+ +, Fe++, Zn + +, Na-thioglycollate, cysteine-Hel, acetate, fuma­
rate, alpha-glutarate, malate, oxalactate, pyruvate, succinate, citrate and vita­
min mixtures (riboflavin, thiamin, biotin, niacin, p-aminobenzoic acid, calci­
um panthothenate, pyridoxine, pyridoxal, pyridoxamine and folic acid) had 
neither appreciable potentiation or reversal of the bacteriostatic ability of 
erythromycin. Haight and Finland (2) found that various concentrations 
of NaCl, dextrose, Na-thioglycollate, cysteine·HCl, semicarbozide, urea, 
glutamic acid, p-aminobenzoic acid and pteroylglutamic acid had no signif­
icant effect on the in vitro inhibition of Bacillus cereus no. 5 by erythromycin. 
They also reported that various concentrations of the sodium salts of citric, 
pyruvic, acetic, lactic, fumaric and succinic acids and the enzyme penicil­
linase had no effect on the inhibition of St-rep/ococCtfJ no. 98. Hun1an sera 
at various levels had no effect on the antibiotic's inhibition of Sarcina It/Jea. 
Brown and Emerson (3) reported that 500 mcg/Il1l beta-alanine or calcium 
pantothenate, equivalent to 200 mcg/ml beta-alanine, permitted growth of 
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COI')'l7ebaderilllll diphlhe1'icle in 70 times the original minimal inhibitory con· 
centration of erythromycin. L·carnosine, equivalent to 100·400 l11cg/ml of 
beta-alanine, reversed the inhibition of up to 30 times the minimal inhibitory 
concentration of the antibiotic. 
Haight and Finland (2) found a 530 and 800·fo[d increase of the in vitro . 
inhibitory activity of erythromycin against Streptococct/s no. 98 and Sm'cilla 
INtea. respectively, when the pH was increased from 5.6 to 8.5. Pittenger 
et ai. (1) found a 30- fold increase in the bacteriostatic action against hlicro­
coatis pyogenes var. t/l/1'n/J with the increase of pH from 6.5 to 8.5. They 
also noted that an apparent potentiating effect of phosphates on the activity 
of erythromycin was actually due to the effect of the buffering action on pH. 
Pittenger et al. (1) suggested that the free base had much more activity than 
the salt of the antibiotic and that the increase of activity as the pH increased 
was due to release 0 f the free base. 
Haight and Finland (2) found that a change in the pH by replacing the 
oxygen with carbon dioxide did not affect the bacteriostatic action of erythro­
mycin against Streptocou!fJ no. 98, StreptococotJ C203, S<lrCilU/ lutecl: Strep
tOCOCClif viridt/llJ) DiplococntJ pnell1170niae type III, S/aph)'locoCl'ttJ no. 195 
or an enterococcus. 
Resistance has been developed in sensitive strains in the laboratory. Pit­
tenger et ai. (1) found that J'rlicl'omcCfts pyogel!eJ var. o,,/·ret/.f increased its 
resistance to erythromycin about 300-fold in 25 serial transfers in the pres­
ence of the antibiotic. The development of resistance to erythromycin was 
slightly less rapid than the development of resistance to penicillin and much 
Jess rapid than the development of resistance to streptomycin under the same 
conditions. No organism which had become nutritionally dependent on 
erythromycin was found. Hsie and Kotz (30), however, developed a strain 
of M. pJogenes var. aflrellJ which had become nutritionally dependent on 
carbomycin. 
Haight and Finland (2) attempted to determine whether species which 
are naturaJly resistant to erythromycin produce erythromycinase. Using the 
method of Gots (31) numerous strains of Pseudomonas cleruginoJtI, Aero­
bacter aerogenes: Klebsiella pneumoniae, E.rcheriehici coli, Pwtetts vulgaris, 
Salmonella and Shige!!a were checked for the production of an extracellular 
erythromycinase which would destroy erythromycin which was present in an 
amount just inhibitory to the test organism, Sarcina lutea. No evidence of 
destruction of the antibiotic was found. By a second method, suspensions of 
Proteus llUlgMis and Escherichia coli organisms had no destructive effect on 
a solution of erythromycin over a 72-hour period. 
Obviously. there are present in nature mechanisms for the destruction of 
, this antibiotic. The erythromycin content of pLasma in vivo drops rapidly
I without a corresponding amount being excreted in the urine or otherwise 
being accounted for (2). One scrap of evidence of its metabolism has been 
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found. Des-N-methyl erythromycin has been isolated from the bile of dogs 
(32). 
Stone et al. (5) found that coagulase-positive strains of i\tficrococctIJ 
pyogel1es var. alJretrs which had been isolated from human cases showed 
large variation in in-vitro sensitivity but showed smalJ variation in in-vivo 
sensitivity to erythromycin. Inhibition in vitro was caused by 0.195 mcg/ml 
erythromycin for strain no. 3055A, 10,000 mcg/ml, for strain no. 3066A, 
and 5,000 mcg/ml, for strain no. 3072A. In 20 to 25 g Swiss mice, the ef­
fective dose of erythromycin 50 per cent of the time was 18 mcg for strain 
no. 3055A, 22 mcg for strain 00. 3066A and 116 mcg for strain no. 3072A. 
Of significance, in interpretation of this work, is the widely accepted belief 
that coagulase production is the best indication of pathogenicity in strains of 
•jltI. pyogenes VaL tIt/rells (33). Boniece et al. (34) found that erythromycin 
was effective in reducing the coagulase activity of numerous strains of M. 
pyogenes var. atrret/J. 
In one of the few papers on the effect of erythromycin on enzymes, Ja­
cobson and Ayevedo (35) reported that erythromycin did not inhibit fll­
merase, lipase, cholinesterase and thiaminase from animal sources or the 
fermentation of alcohol by yeast. 
MATERIALS AND METHODS 
Materials 
ORGANISMS: 
Bacilllis Sf/btllls, spore sllspension, strain X12.1. R. C. Pittenger 
COfJlleb4eterill1JJ diphlhe,.iae, strain X166, R. C. Pittenger. slrain Toronto. McClain 
Diplococc,,-, pTiellmoui"e. strain type 1, Park 
UCiobacillus c({sei, no. 7469. American Type Culture Collection 
MicrococCl/s !,jogenes vae. "",euf; strain no. 3055. strain no 3066, strain no. 3067, 
strain no. 3074. all from Boniere 
P"JleIlS ,'",/garis. strain no. 9484. American Type Culture Collection 
Pseudomol/as (/erugillosa, slrain X239. R. C. Pittenger 
SlrepIOCOC(JIS p)'o,~efleJ. C203, strain no. 8868. American Type Culture Collection 
SdCC!JIlY07l1Jces cere"i.. iae; "Gebriider Marer:' strain no. 7752, "Old Process," Slrain 
no 7753, "Fleischmann's Baker's," strain no. 7754, A'nerican Type Culture 
Collection 
MEDIA: 
Brain heart infusion (Difco) used with COf)'i1ebtJclelll/liI 
Hydroly:<erl caselll Inedium (>6) used "ith i\11CJ'OCOCCII.' 
Mycin assa}' ager (Diko) used with B,1/I1I1I" sl/blllis 
Tryplose- (Difro), l per cent, in nutrient broth (Difm) used with Cor)'llebaClculI1II 
Pantothenic acid assay mediul11 (Difco) used with Lactobacilllls 
Seed agar (Balti.lllore Biological Laboralories) used with Mlcrococcl/s. Prolell, and 
PseudomoJ/(/J" 
Tryptose medium (37) used with Dlploco((uj and StreplOfOCfI/S 
YI:ast synlhetic medium (38. 39) used with yeast 
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INSTRUMENTS: 
Laboratory Model G. Bedcll1an pH l\1eter 
Junior Speetrophutometer, Model 6A, Coleman Instruments, Inc. 
OTHER MATERIALS: 
Alumina A-,03, Aluminum Company of America 
Discs of very pure, highly absorbenr paper for the assay of penicillin and other anll­
bacterial substances, i·in (12.7 mm) dialfi, No. 740-E, Carl Schleicher and Schuell 
Erythromycin standard solution. 100 mcg/In!' One hundred mg 'Ilotycin' (erythro· 
lfiycin, Lilly), lot no. 652282. was dissolved in 100 ml 1 per cent sndium and 
potassium phosphate solution adJnsted to a pH ot 7.0 (Hartman-Leddon Co.) 
and filtered through a SeiTZ tilter. So)ntion was made nl' fresh at ]east once a 
month and stored in a refrigerator unlll used. 
"Tes-Tape," a paper impregnated wiTh glucose oxidase and horse·radish peroxi­
dase, Eli Lilly Company 
Screening of CompoundJ to Determille Reversal or Polenlitllioll of Arlion of 
Erylhromycin 
Method of Screening. Work was begun using seeded agar plates to which 
erythromycin was added on a centrally located paper disk. Solutions of com· 
pounds to be tested were added to paper disks which had been placed on the 
agar. Part of the disk would cover agar in which the antibiotic would diffuse 
from the erythromycin disk and would be expected to inhibit growth. Part 
of the disk would cover agar where no inhibition would be expected to occur. 
It was decided that seeded plates, in which a bacteriostatic threshold level 
of erythromycin was present, would constitute a sensitive means of demon­
strating any reversal action that a compound might have. In this event the 
disk to which an active compound had been added would be surcounded by 
a circular zone or a halo in which growth of the test organism took place. The 
diameter of the zone would be related to diffusability of the compound as 
well as to its inherent activity. 
MirrococclIJ pyogeneJ vat. aUl'etlJ no. 3055, a strain sensitive to several 
antibiotics, and spores of Barillus .wblilis were used for these tests. Synthetic 
media were tried first and found unsatisfactory, Seed agar (BBL) was used 
with M. pyogenes and mycin agar (Difco) was used with B. subtiIi;. Ten 
ml of heated liquid agar was poured into a Petri dish. After the agar base 
had hardened, 5 ml additional liquid agar containing 0.5 ml of a 1/100 
dilution of either organism and, when indicated, containing 0.5 ml of the 
appropriate concentration of erythromycin, were layered in on top. When 
M. pyogenes was used, 50 mcg of the antibiotic was either incorporated in 
the seeded agar or added to the paper disk. When B. subtilis was used, 10 mcg 
of the antibiotic was used. The antibiotic was added to the paper disk in 0.05 
m[ quantities; solutions of test compounds were added in 0.07 ml quantities. 
To prevent absorption of moisture from the medium by the paper disks, 
solutions were added to the disks immediately after they had been placed on 
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the agar. Plates were incubated at 37°C. for 24 hours and then examined for 
growth. 
Compounds Screened. A large number of compounds were screened for 
effect on the inhibitory action of erythromycin against Microcorws pyogenes 
vaL dUI'eIlS and the spores of Bc/cillus slIb/.i1iJ, using both techniques. Com­
pounds and their per cent concentration in solution were as follows: 
amino acids: DL-alpha.alanine, 1 and 10; beta-alanint-, O.l and 10; L.arginine, 1; 
DL-aspartic acid, 1 and 2; hydrolyzed casein. (vitamin·[rt-e). 10: DL-citrulline, I: 
creatine. 1: L·cysteine·HCI, 1 and 10: ethionine. 1; L-gl utamic acid, 1 and 2: 
L·histidine·HC!. I and 5; DL-isoleucine, 2; L-Ieucine-HCI, 1: DL-Iysine-HCI. 1; 
DL-1l1elhionine, I: norleucine. 1; DL·pht-nylaLtoine. 1; L-proline, 1; DL-serine, 
1: DL-threonine. 1: DL-tryptophan. 1; DL-valine. 2 
purines: adenine sulfate, 1; guanine-HCI, 0.7: uracil. 1: xanthin.e, 1 (All purines 
were brought into sollittOn with NaOH.) 
organic acids: citric acid, 1 and 10; oxalic aCid, 1 and 10 
vitamins: acetyl choline·HC!' 10: ascorbic acid. 1; bela-alanine. 0.1 and 10; biotin, 
O.OOO,O·i, Ca-pantothenate, 0.1 and 1; inositol, 0.1; niacin, 0.06: p·aminobe07oic 
acid, I; pimelic acid. 0.025; pyridoxine. 0.12, thiamine-HC!. 0.1; yeast extract. 10 
carbohydrales: dextrost-, J0: lactose, 10: levulose, 10: D-I\lallose, 1: mannost-, I; 
mannitol, 10; ratllnose. 10, rhamno"e. 2. ribose. 1; ,ucrose. 1 and 10: xylose, 10 
miscellaneous organic compuuods: adeoylic acid, 1: L-asparagine, 1 and 10; beef ex­
tract, 10: betaIne, I; cr<:atinine, 1; desosanllne, 10: D-glucosamine. 1: glutathio­
nint-, 1; glyC<:IOI. 10; mercaptoethyJ amine; 10: mucio. 5; Na-thioglycollate, 1; 
tetla sodium salt of ethylene diamint- tetra acetic acid, 9.4 
inorgaoic compounds: FeSO..7H,O, 0.1 and 10: KCJ, 0.1; ZnSOdH,O, 0.1: 1'150" 
0.1; HJBO" 0.1; NaH,PO, and Na,HPO, (pH 7.0), 10 
Hydrogen [on fOilcen/.rfl/.;on. The pH was determined for all samples 
screened which had not been previously discarded. 
Since some of the compounds which reversed erythromycin were fOund to 
have pH's of 4.0 or less, the pH's of the solutions of seven of these com­
pounds, adenylic acid, ascorbic acid, L-aspartic acid, L-cysteine-HeI, L-glu­
tamic acid, glutathione and L-histidine-HCI, were brought up to the range 
of 6.0 to 7.0. Solutions of these neutralized compounds were added to paper 
disks on seeded plates containing a bacteriostatic amount of the antibiotic 
and checked for reversal of the action of the antibiotic. 
L.Cy.rleiJ7e-Hydrorhloride. This compound was tested for reaction with 
erythromycin under mildly acid conditions. A 0.2 per cent L-cysteine-HCI 
solution was made in erythromycin standard solution and the pH adjusted to 
5.2. As a control, erythromycin standard solution was adjusted to a pH of 5.2. 
The cysteine-erythromycin and control solutions were heated in a 56°C. 
water bath for 1 hour. fifteen ml of each solution were filtered through a 
Seitz filter and compared, using paper disk assay techniques with both test 
organisms. The diameters of the zones of inhibition were measured and com­
pared as an indication of comparative potency. The remainder of the cysteine­
erythromycin and control solutions were stored in a refrigerator at 6°C. for 
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Organic and Inorganic acidJ. In view of the data which showed that com­
pounds which reverse the action of erythromycin were acidic, additional acid 
substances were tested in the same manner as the original screening. Sub­
stances tested were alanine 2 per cent and HCl 1 per cent, glycine 2 per cent 
and HCl 1 per cent, HCl 1 per cent, lactic acid 1 per cent, malic acid 1 per 
cent, H~SO~ 1 per cent and tartaric acid 1 per cent. 
i
Rev;!Jal. Finally, chemicals with the ability to reverse the action of erythro­
mycin, including aciclic substances, were checked for revival of organisms 
which had been inhibited by erythromycin. Agar plates seeded with either test 
organism and containing bacteriostatic concentrations of erythromycin were 
incubated at 3rc. for 24 hours. Solutions of test compounds were added to 
paper disks on the surface of the agar. The plates were incubated an addi­
i 
I
 tional 4R hours and then examined for revival of organisms.
 
Investigation of the Rewl'Sal by Calcit/m Pantothenafe and Beta-Alanille 
of the Inhibitory Effects of Erythl'Omycin 011 Se1Jerai Spec;eJ 0/ Bacter;a 
Laclobacill/ls c,He;, L. (,lSei was used to determine if Ca-pantothenate and 
beta-alanine have the ability to reverse the inhibition caused by erythromycin. 
The procedure followed was that of the Difco Manual (40). Amounts of Ca­
pantothenate added to the tubes were equivalent to 0, 0.02, 0.2, 2 ancl 20 
mcg/ml of the final voltHne. four tubes containing each level of Ca·panto­
thenate received 0, 0.04, 0.2 and 1 meg erythromycin per ml of the final 
volume, respectively (Tahle 1). Distilled water was added to bring the 
volume to 5 mL Five ml pantothenic acid assay medium was added. The cuI· 
ture tubes were sterilized by autoclaving and then inoculated with a suspen· 
sion of washed L. cClse;. The cultures were incubated at 37°C. for 72 hours. 
The pH was determined for each culture. An interpretation was made on 
the basis of pH as an indication of growth and acid production. This test 
was repeated. Subsequently, a test was set up in which all tubes recei I'ed 
0.2 mcg/ml Ca-pantothenate. Amounts of beta-alanine added to tubes were 
0, 0.2, 2, 20 and 200 mgc/lnl of the final volume. Four tubes containing 
each level of beta-alanine received 0, 0.2, 2, and 20 meg erythromycin per 
ml of the final volume, respectively (Table 2). 
Saccharomyces cerevis;ae. Three strains of S. cere1J;riae. "Old Process," 
"Fleischmann's Baker's" and "Gebriider Mayer," were checked for their 
requirements of Ca-pantothenate. Using the synthetic medium of Williams 
et a!. (38, 39) "Gebruder Mayer" gave the greatest response to the addition 
of Ca-pantothenate to the medium. A test was set up with all tubes in du­
plicate. Amounts of Ca-pantothenate added to the tubes were equivalent to 
0,0.005,0.01,0.02,0.03,0.04 and 0.05 mcg/ml of the final volume. Eight 
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tubes containing each level of Ca-pantothenate received 0, I, 10 and 100 
mcg erythromycin per ml of the final volume for each pair, respectively 
(Table 3). After inoculabion, tests were incubated at room temperature for 
5 days. Readings of optical density were made at a wave length of 550 
lambdas with a spectrophotometer. Subsequently, anot.her test was run in 
which amounts of beta·alanine added to the tubes were equivalent to 0, 0.2, 
0.4, 0.6, 0.8 and 1 mcg/ml of the final volume. Eight tubes containing each 
level of beta·alanine received 0, 1, 10 and 100 mcg erythromycin per ml of 
the final volume [or each pair, respectively (Table 4). 
j\1icrococrus pyogenes var. atlreus. M. pyogenes var. aw'eus, strains no. 
3055 and no. 3067, were investigated using hydrolyzed casein medium (36). 
Amounts of Ca'pantothenate added to the tubes were equivalent to 0, 0.1, 1 
and 10 mcg/ml of the final volume; amounts of beta.alanine, were equivalent 
to 0, 10, 100 and 1000 mcg/ml. for each strain a set of four tubes at each 
level of Ca-pantothenate or beta-alanine received 0, 0.1, 0.2, 0.5, 1 and 2 
mcg erythromycin per mL of the final volume, respectively (Table 5). After 
inoculation, cultures were incubated at 37°C. for 5 days. Growth was de­
termined by a visual estimate of the turbidity. Very heavy growth was given 
a value of 4; heavy growth, 3; moderate growth, 2; slight growth, 1; and no 
growth, O. 
Streptocot't't/s pyogenes and DiP/ococctl.!' pnelltl7or/ide. S. pyogeneJ C-203 
and D. pneumonie/e Park type 1 were investigated using tryptose medium 
(37). Amounts of Ca-pantothenate added to the tubes were equivalent to 
0, 0.1, 1 and 10 mcg/ml of the final volume; amounts of beta-alanine, were 
equivalent to 0, 10, 100 and 1000 mcg/ml. For each organism a set of four 
tubes containing each Level of Ca-pantothenate or beta-alanine received 0, 
0.005, 0.01, 0.02 and 0.04 mcg erythromycin per ml of the final volume, 
respectively (Table 6). After inoculation, cultures were incubated at 37°C. 
for 4 days. Growth was determined by a visual estimate of the turbidity. 
CO''J'l7ebaderium diphtheriae. C. diphtheriae strains X-166 and Toronto 
were investigated using a medium of 1 per cent Tryptose (Difco) added to 
nutrient broth. Amounts of Ca-pantothenate added to the tubes were equiv­
alent to. 0, 0.1, 1 and 10 mcg/ml of the hnal volume; amounts of beta-alanine, 
were equivalent to 0, 10, 100 and 1000 mcg/ml. For each strain four tubes 
containing each level of Ca-pantothenate or beta-alaniue received a, 0.004, 
0.0008, 0.016 and 0.032 mcg erythromycin per ml of the final volume, re­
spectively (Table 7). It was necessary to use a large inoculum to get satis­
factory growth. One drop of undiluted 5-day culture was used. After 
inoculation, the cultures were incubated at 37°C. for 9 days. After vigorous 
shaking, the growth was determined by a visual estimate of turbidity. 
Pantothenic Acid P.roduction by Resistant SUe/im of Micrococcus pyogenes 
val'. aUfeus. Two resistant strains of lV{. pyogenes var. at<reus, no. 3066 and 
no. 3074, and sensitive strain no. 3055 were grown in hydroLyzed casein 
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1 medium without the presence of pantothentic acid and beta-alanine. After in­oculation, the cultures were incubated at 37°e. for 24 hours. A 10 ml ali­
I <juot of each culture was autodaved at 15 lb. steam pressure for 15 minutes. 
To each culture was added 10 ml4 per cent acetic acid, 2 ml Nil NaOH andI 
'I 
1 g mylase. The tubes were placed in a 50°e. water bath for 24 hours. The' 
I pH was brought to 7.0. These salnples were assayed for pantothenic acid 
llSlOg Lac/obc/cillIJJ celse; in the manner earlier described. 
I
 /mJestiga/ioll of the Presem'e of /1l/fCice/lti/ar 01' Ex/r4celltt/ar
'r Erylhl'omycil1ase 
1 
I GOls' Method, Ex/racelltllclr Ery/hromyciI14se. Using the method of Gots 
(4), ProteI'S mt!gllris. Pseudomonas aeruginosa and resistant strains of l'vei­
crococCt/s pyogenes vae. aureus were checked for the production of extracellu­
lar erythromycinase. Seed agar (BBl) plates were prepared which were 
~ 
seeded with sensitive strains M. pyogenes vae. clttreus, no. 3055 and no. 3067 
and which contained 1.4 mcg erythromycin per m!. The plates were streaked 
WIth the above mentioned resistant organisms. The plates were incubated at 
37°e. for 24 hours and examined for the growth of the seeded organisms in t 
I the agar. 
Breakdown of E1'Ylh1'omycill in Sollllion by EXlfacell"lar Erythromycin4se. 
ReSIstant strains of Mic'rococclls pyogeneJ var. aUI'ellS, no. 3066 and no. 3074 
were used in a second check for the production of an extracellular erythro: 
myclllase. It had been previously determined that these strains could b"row in 
t.he presence of 200 meg erythromycin per m!. Cellophane tubes containing 
) mJ hydrolyzed casem medium (36) were immersed in 25 ml of the same 
medium in 40 mm diam culture tubes. The dialyzing tubes were inoculated 
with resistant strains no. 3066 and no. 3074, respectively, and 100 mcg 
erythromycl,n per ml was added to the medium surrounding the dialyzing 
tubes. A thud tube was jnoculated with sensitive strain no. 3055, no anti­
biotic being added to the medium. A fourth tube was prepared in which 
erythromYCin was added but no inoculation was made. After 72 hours incu­
bation at 37~e.,. dilutions were made of the media outside of the dialyzing 
tubes. The ddutlOns were made in hydrolyzed casein medium in 2-fold steps 
from 1:2 to 1 :64. The diluted medium was then inoculated with sensitive 
strain no. 3055 and incubated at 37°e. for 2 days. The presence or absence 
of growth in the dilutions was noted. 
Solllen/Treatment of Cells 10 Release Illlt'acellttlar Er)'/hromycin. Abraham 
and ~hain (41) originally found penicilJjnase as an intracellular enzyme by 
grInding up cells of EJChericbia coli, Kirby et al. (42) found that the treat­
ment of MiCfOCOCClIs cells by fat-removing solvents, acetone and ether, was a 
satisfactory means of making intracellular penicillinase avai/able. Gilson and 
Parker (43) found that by using the solvents at temperatures of - 20°e. 
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they had less inactivation of the enzyme. Adapting the method of Gilson and 
Parker to the facilities available, resistant strains, no. 3066 and no. 3074, of 
/Y!icrOCO((!15 pyogenes var. allreJIS were checked for the production of 
erythromycinase. 
The entire surface of plates of seed agar (BBL) was inocuhlted with a 
suspension of the resistant i\tL pyogmes strains. Two plates were inoculated 
with each strain. After 24 hour incubation at 37°e., 3 ml sterile saline solu­
tion were added to each plate. The organisms were suspended in saline solu­
tion. About 5 ml of suspension of each strain were harvested and added to a 
. 'f 
centrifuge bottle. Each centrifuge bottle was placed in a beaker of alcohol 
which had been cooled at -20°e. Twenty-eight ml of acetone, cooled to 
-20°e., were gradually added with shaking. The suspension in the centri­
fuge bottle was maintained within the range of -1O°e. to - 20°e. After 75 
minutes with frequent shaking, the acetone was removed with suction. An 
addition,l! 25 ml of -20°C. acteone was added to the residue and the sus­
pension maintained at -100e. to -20°e. with frequent shaking for 75 
minutes. The acetone was again removed with vacuum. This time, 25 m: of 
-20°e. ether were added to the residue and the suspension maintained at 
-10°e. to -20°e. with frequent shaking for 75 minutes. The ether was re­
moved with suction. The residue in the centrifuge bottle was dried by 
evacuation to a pressure of below 100 microns Hg for 1 hour. 
Erythromycin was added to hydrolyzed casein medium at dilutions from 
1 meg to 200 mcg per ml of final volume. One series of tubes served as con­
trols, a second series received a suspension of no. 3066 treated cells; a third 
series received a suspension of no. 3074 treated cells. All tubes were inoc­
ulated with a suspension of the sensitive no. 3055 strain. excepting sterility 
controls. Since sterility controls on inoculation indicated that viable M;cro­
COCOIS cell,r were present in the residues, another plan was necessary to dem­
onstrate the presence or absence of erythromycin. 
An erythromycin standard solution was brought in contact with the de­
fatted cells, sterilized by filtration, and checked for destruction of the anti­
biotic. A tube containing 3 ml of erythromycin standard solution, 1000 meg 
of the antibiotic per ml, received 1.7 mg of defatted no. 3066 cells; a second 
tube received 4.1 mg of defatted no. 3074 cells; a third tube received no 
cells and acted as a control. All tubes were left at room temperature for 48 
hours. Twelve ml distilled water were added to each tube and the contents 
then filtered through a Seitz filter. Dilutions of the filterates added to hy­
drolyzed casein medium were equivalent to 0,0.10,0.39,1.56,6.25,25 and 
100 meg of erythromycin originally present per rol of final volume. All tubes 
were inoculated with the sensitive strain no. 3055 of iV[. pyogenes var. ttureus. 
After incubation at 37°e. for 4 days, the tubes were examined for growth. 
Physical De,rlt'ucliol1 of Cell Wall to Release Intracelllllar Erythromy­
cjut/se. According to Hugo (44) and McIlwain (4:;), a very satisfactory 
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1 method of preparing cell-free enzymes is by the physical rupturing of the cell wall with fine abrasives. Resistant strains no. 3066 and no. 3074 of M;­
crOWCCNS pyogenes var. maetl.. and the resistant organisms Protetls 1Jttlgtlris 
and Pseudomol1t!S aeFugil70sa were treated in this manner to determine the 
presence of intracellular erythromycinase. 
The entire surfaces of two plates of seed agar (BEL) were inoculated with 
each strain of organism used in this experiment. After 24 hour incubation at 
37°e.. 4 ml sterile saline solution were added to each plate and the organ­
isms therein suspended. About 8 ml of each strain were harvested aud placed 
in a centrifuge tube. The cells were centrifuged down in an angle head centri­
fuge and had a final volume of about V4 ml. The residue was transferred to a 
cooled sterile mortar. Six-tenths g of Alumina A-303 were added. The cells 
were ground with a pestle for 1 minute following the procedure described by 
cetooe was removed with suction. An 
was added to the residue and the sus­
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McIlwain (4»). The ground cells were resuspended in 2 ml sterile saline 
solution and 1 ml erythromycin standard solution. The suspensions were re­
frigerated at 6°e. for 24 hours and then left at room temperature for 24 
hours. Next they were diluted with 27 1111 distilled water each and were 
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the centrifuge bottle was dried by 
microns Hg for 1 hour. 
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n no. 3055 of M. pyogenes var. aureus. 
the tubes were examined for growth. 
to Release Intl'acellular Erythromy­
McIlwain (45), a very satisfactory 
sterilized by filtration through Seitz filters. The filtrates were added to hy­
drolyzed casein medium in amounts eguivalent to 0, 0.1, 0.4, 1. 2, 3.7 and 11 
mcg of erythromycin originally present per ml of final volume. All tubes 
were inoculated with the sensitive strain no. 3055 of M. p)'ogenes var. eU/rellS. 
After incubation at 37°e. for 3 days, growt.h was determined by visual in­
spection. 
The Effect of Erythrom)'cin 011 the Actioll of Cot/gulase timl Othe1' Enzymes 
Coagulase tests were carried out in a manner similar to that described in 
the Difco Manual (46). Plasma was prepared from rabbit blood to which 
1 per cent Na-oxalate was added. Dilutions of erythromycin were made in 
distilled water with erythromycin standard solution. Derivatives of erythro­
mycin were dissolved or suspended in distilled water. Micrococcus pyogenes 
var. rlf.lreus was grown in Brain Heart Infusion (Difco) at 37°e. for 24 
hours. Suspensions of the organisms were staudardized at 42.5 per cent light 
transmission at a wave length of 550 lambdas in a spectrophotometer. Five­
tenths ml plasma were measured into an 11 mm by 65 mm culture tube; 0.1 
ml erythromycin solution, derivative solution or water was added; 0.1 ml 
standardized suspension of 1\1'. pyogenes var. at/rellJ cells was added last. 
Each tube was mixed by shaking and placed in a 37°e. watcr bath. Tubes 
wcre examined for coagulation every 5 minutes for thc first 30 minutes and 
every 10 minutes up to 3 hours. The amount of coagulation was estimated 
by the apparent viscosity of the plasma. A numerical value of 4 was assigned 
when the tube could be inverted without displacement of the plasma from 
the bottom of the tube; a value of 0 was assigned when there was no ap­
parent change in viscosity. 
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A preliminary study was made on the effect of the addition of erythromy­
cin or its derivatives at the time of growth on the formation of coagulase by 
IVI. pyogcllcs var. clt/rellS. Tubes containing 5 ml casamino acid medium to 
which had been added 12.5, 5 and 1.25 mcg erythromycin, 5 mg desosamine, 
5 mg erythralosamine, 5 mg dihydroerythronolide, C~lHH08' and a control 
were inoculated with strain no. 3055. A control medium and a medium with 
100 mcg erythromycin added were inoculated with strain no. 3066. The co­
agulase action of these cultures was noted for the first 60 minutes. The ef­
fect of the addition of 100 mcg erythromycin at the time of the coagulase 
test on the coagulase activity of strain no. 3055 was also determined. 
., 
A second series of tests was carried out using cultures of sensitive ~trains 
no. 3055 and no. 3067 and resistant strains no. 3066 and no. 3074 grown in 
brain heart infusion alone and resistant strains no. 3066 and no. 3074 grown 
in the presence of 100 mcg erythromycin per ml. The coagulase activitj, was 
determined for each of these six cultures alone with the addition of 100 mcg 
erythromycin at the time of test. 
A third series of tests was carried OLlt using cultures of strains no. 3055, 
no. 3066, no. 3067 and no 3074 grown in brain heart infusion. At the time 
of test, 0, 0.1, 1. 10 and 100 Incg erythromycin were addc:d to ph;ma tubes 
with each strain of j"f. pyogenes Vaf. al/rellS to determine the effect on co­
agulase activity of erythromycin. 
A fourth series of tests was carried out to determi ne the effect of several 
degradation products of erythromycin on the coagulase activity of lYf. pyo­
genes vae. 4t/ret/S. At the time of test 1000 mcg desosamine, 1000 mcg cia­
denose, 100 mcg dihydroerythronolide, 100 mcg erythralosamine, and 1 mcg 
erythromycin were added in 0.1 ml distilled water to 0.5 oxalated plasma. 
One·tenth ml of suspended cells of M. pyogenes was added to each tube as 
well as to a control. Strains no. 3055, no. 3066, no. 3067 and no. 3074 were 
used. The time of coagulation of each tube was noted. 
The new clinical aid, "Tes.Tape," depends on the activity of glucose 
oxidase and horse· radish peroxidase to determine the presence of glucose in 
the urine. A 40 mm strip of "Tes-Tape" was wet with 0.05 ml erythromycin 
standard solution and allowed to air dry. The antibiotic treated strip and a 
control strip were both wet with a 1 per cent glucose solution. Both strips 
were dried in the air for 1 minute. The depth of the color of each strip was 
compared with the color chart on the tape dispenser. 
RESULTS 
Screening of Compounds 10 Defermine Rn'erJaL of PolCiltia/ion of AtJ.;oll of 
Erythromycin 
Compollnds SCfeCiled. Several of the compounds screened showed some 
form of activity. Some of these substances reversed the inhibition of the test 
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The following compounds reversed the inhibition of test organisms b'y 
erythromycin. The diameters of the growth zones on plates seeded with Mi­
crococo/J pyogene.r var. at/rem and spores of BC/cililis slIbtilir are here listed: 
adenylic acid, 1 per cent: B. [., Itl to 19 mill 
ascorbic acid, I per cent: M. p., 14 mm; B. r., 14 to 18 111m 
DL-a~partir acid, 2 per cent: M. p.. 15 to 24 111m; B. S., 19 to 26 111m 
citric acid, 1 per cent: M. p., 22 mm, B. r., 18 to 27 mm 
L-cysteine-HCI, 10 per cent: M. p., 23 to 33 nl1n; B. .1'., 27 to 34 111m 
L-glutamic acid, 1 per rent: B. s., 15 to 21 mm glutathione, 1 per cent: M. p.. 19n1l11 
L-hisridine-HCL 5 per cent: M. p., 20 111m; B. S., 22 mnl 
o"alic acid, 1 per cent: M. I' .. 23 Illm; B. r., 27 to 33 mm 
The inhibition of Mirroco({m pyogenes var. tl1lrelfS and spores of Bacillllr 
SttbliliJ by erythromycin was potentiated by adenine sulfate, 1 per cent, 
guanine-HCI, 0.7 per cent, uracil, 1 per cent, and xanthine, 1 per cent. 
A number of the compounds which reversed the inhibition of erythromy­
cin had a halo-like growth zone. In fact, the onl y one of these reversing com­
pounds for which this halo-like effect was not seen was glutathione. Da.ta 
giving the diameter of the inner zone of inhibition is given in the paragraph 
2, page 79. In seeded plates to which erythromycin had not been added, these 
compounds produced zones of inhibition of about the same diameter as the 
inner diameter of the halo in plates to which erythromycin had been added. 
Oxalic acid reacted with both media to form opaque zones around the 
paper disks. 
Toxic effects of jWirt·ococC/lS pyogeJles var. twre/ts and spores of Bacillus 
JJlbtiliJ produced inhibition zones with diameters as follows: 
1 
feSO •. 7H,O, 10 per cent: M. p.. 25 mOl; B. s.. 27 ml<l 
D-glucosamine,l per cent: "'1. p., 25 111m; B. S., 13mm 
mercaptoethyl amine, 10 per cent: B. s., 50 mlU (no sharp threshold) 
thioglycerol, 10 per cent: M. p., 21 mill; B. s., 1(, mm 
tetra sodium salt of ethylene diamine tetra acetic acid, 9.4 per cent: iI1. p., 27 mm; 
B. SO, 34 mIn 
FeS04 .7H20, 10 per cent, and D-glucosamine, 1 per cent, enhanced the 
growth of spores of BClrifftlJ mbliLis with zones 39 mm and 22 mm in di­
ameter, respectively. 
Hydrogen Ion COllcentration. The hydrogen ion concentration was de­
tennined on solutions of all compounds screened except Ca-panthothenate, 
pyridoxine, niacin, biotin, desosamine, ZnS04 .7H 20, TiSO~ and H~BO:>. 
The hydrogen ion concentrations of most solutions were found to lie within 
the pH range of 5.0 to 7.9. Solutions which had a hyd rogen ion concentration 
above or below this range had pH's as follows: 
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~denine sulfate, I per cenl 10.0 
adenylic acid, 1 per cenl 2.7 
ascorbic acid, 1 per ceot 2.5 
Dl-aspartic acid, 2 per ceot 2.9 
belaine, I per cent 4.1 
cilric acid, 1 per cent 2.2 
I.·cysteioe·HCI, 1 per cent 1.7 
I..glutamic acid, 1 per cent 2.9 
glutathione, 1 per cenl 3.0 
guanine HCl, 0.7 per cent lOA 
I.-bistidine·HCJ, 1 per cent 4.0 
mercaptoelhyJ amine, 10 per cenl 4.6 
o~~lic acid, 1 per cent 3.7 
p-aminobenzoic acid. 1 per cent 3.7 
thiamine-Hel, 0.1 per cent 3.7 
uracil, I per cent 9.9 
'anthine. 1 pee cent 10.4 
The neutralized solutions of adenylic acid (4 per cent), ascorbic acid (10 
per cent), L-aspartic acid (5 per cent), L·cysteine-HCI (10 per cent), L­
glutamic acid (4 per cent), glutathione (2 per cent) and L-histidine· HCl 
(5 per cent) gave no evidence of reversing the bacteriostasis of the test or­
ganisms, Micro(O((tJs p)'ogenes var. auretfs and Bacillus SlibliLis; caused by 
threshold amounts of erythromycin. 
L-Cysleine-HC/. Erythromycin which had been treated with L-cysteine­
HCl at a pH of 5.2 at 56°C. for 1 hour gave zones of inhibition with both 
jHin'ococCtis pyogmeJ var. tlltrnlJ and the spores of Be/cil/lls sub/i/is iden­
tical with those obtained from an erythromycin control which had been 
treated with no L·cysteine-HC!. After a subsequent 3-day storage in the re­
frigerator, potencies were still identical. 
Organic and Inorganic A rids. It was found that the inhibition of I\.ficro­
coccus pyogenes var. rwre/IJ and the spores 8<lci//;IS sub/iLlS was reversed by 
a number of organic and mineral acids. Alanine (2 per cent) and HCl (1 per 
cent), glycine (2 per cent) and HCI (1 per lent), HCI (1 per cent), lactic 
acid (1 pe.r cent), malic acid (1 per cent), H2S0~ (1 per cent) and tartaric 
acid (1 per cent) were effective. In the case of B. sub/ilis these ac.ids in the 
aforementioned concentrations caused halo-like zones of growth in plates 
containing threshold amounts of the antibiotic. In the case of M. pyogenes the 
zone of growth extended to the paper disk on which the acid had been added. 
Rui1JaL. It was found that revival of Aficro(o(CIIS pyogenes var. rwreuJ 
and spores of BelcilLIIJ JubtiliJ by a threshold amount of erythromycin could 
be effected by the compounds which had shown reversal action when added at 
the same time as the antibiotic. DL-asparic acid, L-cysteine-HCI and l-histi­
dine-HCl brought about the revival of both organisms. Growth could be seen 
at 24 hours but was much more evident at 48 hours. Only a small pe.rcentage 
of the inhibited organisms were revived. In the case of M. pyogenes va.e. 
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atrretl.l most of these appeared to be growing on the surface of the agar. After 
becoming aware of the importance of the pH of the compounds screened, it 
was found that alanine (2 per cent) and He! (1 per cent), ascorbic acid (4 
per cent), l-glutamic acid (2 per cent), HCl (1 per cent) and H~S04 (1 
per cent) brought about the revival of B. JIIbtilis. The revival of M. pyogeneJ 
var. aure"s was brought about by alanine (2 per cent) and He! (1 per cent), 
ascorbic acid (4 per cent), L-glutamic acid (2 per cent), malic acid (1 per 
cent) and tartaric acid (1 per cent). 
11l1Jestigat;on of lhe Reveuc;/ by Cctlc;UIJ7 Pantothenate and Detcl-A/4Iline 
of Jhe Inhibitory Effec/J of Er)'thro17l}'cin on Severed Specier of Bac/eritl 
LClclobcTc;llu.l CcT.le;. In the studies with L. caH:i it was found that 
0.2 mcg/ml erythromycin caused an increase in the pH of the blank tubes to 
which no Ca-pantothenate had been added after the tubes had heen inoc­
ulated and incubated 3 days at 37°e. One mcg/m! of the antibiotic resulted 
in a still higher pH (less acid production). The minimal inhibitory level of 
erythromycin, i.e., 0.2 mcg/ml erythromycin, 0.02, 0.2 and 2 mcg/ml Ca­
pantothenate caused ,1 reversal of thc inhibitory effect and brought about 
growth. However, when 1 mcg/ml of the antibiotic was present even 20 
mcg/ml of the vitamin caused no appreciable reversal of inhibition (Table 
1). When 0.2, 2 or 20 mcg/ml of erythromycin was present, up to 200 fncg/ 
ml beta-alanine had no growth effect in the presence of 0.2 mcg/nll Ca­
pantothenate (Table 2). 
SClCl:hal"Omyce.l cerel!iJiae. With the "Gebruder Mayer" strain of S. ce­
rev;.litte 10 mcg/m! of erythromycin caused no inhibition. When 100 mcg/ml 
of the antibiotic was present, it took 0.02, 0.04 and 0.05 mcg/m! Ca-panto­
thenate to bring the growth of the ye,lsl to the level, as measured by the 
spectrophotometer, which 0.005, 0.02 and 0.03 mcg/ll11 Ca-pantothenate 
attained in the absence 0[ erythromycin (Table 3). Simih1rIy, it required 
0.4 and 0.8 mcg/ml beta-alanine in the presence of 100 mcg/ml erythromy­
cin to bring about growth equivalent to that of 0.2 an 0.4 mcg/m[ beta­
alanine in the absence of erythromycin (Table 4) . 
It was necessary to use the level of 100 mcg/ml erythromycin to cause a 
reduction of growth of the yeast. It was impractical to use higher concentra­
tions of the antibiotic due to its limited solubility. 
MicrocoCCll.l pyogeneJ var. auretrs. Strain no. 3055 of M. pyogenes var. 
alll'MS was inhibited by 0.5 mcg/ml erythromycin in the absence of either 
Ca-pantothenate or beta-alanine; strain no. 3067 was inhibited by 1.0 
mcg/ml. With 0.1,1 and 10 mcg/ml Ca-pantothenate added to the medium, 
1.0, 0.5 and 0.5 mcg/ml of the antibiotic were required for inhibition of 
strain no. 3055 and 1.0, 1.0 and 1.0 mcg/ml of the antibiotic for strain no. 
195 
3067. With 10, 100 and 1000 mcg/ml beta-alanine added, 0.5,0.5 and 0.5 
mcg/ml erythromycin were required for inhibition of strain no. 3055 and 
1.0, 1.0 and 2.0 mcg/ml, for strain no. 3067. Neither Ca-pantothenate or 
beta-alanine reversed the inhibitIOn of these strains by erythromycin ap­
preciably (Table 5). 
DipLocoattJ pnellmoniae. The growth of D. pJZelll770niae was partiaJly in­
hibited by 0.005 mcg/ml erythromycin and completely inhibited by 0.01 
mcg/mI in the absence of Ca-pantothenate or beta-alanine. The presence of 
0.1, 1 and 10 mcg/ml Ca-pantothenate, the organism was inhibited by 0.01 
mcg/ml of the antibiotic at all levels. In the presence of 10, 100 and 1000 
mcg/mJ beta-alanine, the organism was inhibited by 0.01 mcg/ml erythromy­
cin at all levels. Neither growth factor reversed the inhibition of the organ­
ism by the antibiotic (Table 6). 
Streptococcus pyogener. The growth of S. pyogelles was partially in­
hibited by 0.005 mcg/mJ and completely inhibited by 0.01 or 0.02 erythro­
mycin in the absence of Ca-pantothenate or beta-alanine. In the presence of 
0_1, 1 and 10 mcg/ml Ca-pantothenate, the organism was inhibited at all 
levels by 0.02 mcg/ml of the antibiotic. In the presence of 10, 100 and 1000 
mcg/ml beta-alanine, the organism was inhibited by 0.01, 0_02 and 0.02 
mcg/mI o[ the antibiotic, respectively. Neither Ca-pantothenate nor beta­
alanine caused any appreciable reversal of the inhibition of S. PJogel1es by 
erythromycin (Table 6). 
Corynebtlclerittm diphtheride. The inhibition of C. diphtheriae by erythro­
mycin showed no sharp cut-off point. A 0.004 mcg/ml concentration of the 
antibiotic permitted maximum growth of the organism; 0.008 mcg/ml, 
permitted heavy growth; 0.016 mcg/mL permitted moderate growth; and 
0.032 mcg/ml, permitted slight growth. In the presence of 0.1 and 1 mcg/ 
mI Ca-pantothenate or 10, 100 and 1000 mcg/m\ beta-alanine, the different 
concentrations of erythromycin produced the same pattern of inhibition as 
in the control which received neither nutrient. When 10 mcg/ml Ca-panto­
thenate was used, the pacti<tl inhibition caused by 0.008 and 0.016 mcg/ml 
erythromycin appeared to be reversed and that caused by 0.032 mcg/ml of 
the antibiotic was not affected (Table 7). 
GOIJ' Me/hod. Using the two sensitive strains of i....ricrocoafls pJogenes 
vae. aurelts, no_ 3055 and no. 3067, in seeded pbtes, there was no evidence 
that the resistant strains of AI. pyogenes vae. tlt/relfS, no. 3066 and no_ 3074, 
or the resistant organisms ProteuJ -/Julgtlris and Pseudomonas f.1emginosa 
produced a metabolite which was capable of diffusing through the <tgar and 
reversing the inhibition of erythromycin. 
PfodllCtio17 of Pt:mtothenic Arid by Resisl{//]1 Slrt:li/lS of 111icroco(o!S pyo­
genes lJar. (/uretJs. Mylase-treated, autoclaved suspensions of resistant and 
sensitive strains of iVI. pyogenes were assayed for pantothentic acid content. 
The suspension of sensitive strain no. 3055 contained 0.51 mcg/mI panto­
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111lJeSligaliol1 of Ibe PreJeilte of llllrtlreltillar and EXlrace!/u!cll' 
Erythrom yrlll<1Je 
GotJ' 11Jethod. Extracellu!ar Erythro171)'riil<lJe. Using the method of Gots 
(4), agar seeded with sensiti ve strains no. 305.5 and no. 3067 of Il-[icrocoe­
CIIJ pyogene.. vaL at/reus gave no indication of a diffusible extracellular 
erythromycin,lse in either resistant strains no. 3066 and no. 3074 of AI. pyo­
ge17er var. auret/J or in the resistant organisms Protein IwlgcrriJ and PJell­
domona,r eumginoJa. Using bacteriostatic amounts of the antibiotic in the 
agar, there was no growth of the sensitive seeded organisms in the proximity 
of rhe resistant organisms. 
J Breakdoll'll of Erythromycin ill Sollilion by Exlrdcelll!iar Er}'lhlOm ycincjJe. After incubation the erythromycin containing media surrounding the dialyz­
ing tubes which were inoculated with resistant strains no. 3066 and no. 3074 
of iHicrofOcms PJogmes var. tlllreus and the antibiotic control still inhibited 
the growth of the sensiti ve strain no. 3055 at dilutions up through 1 :64. The 
second control. which contained no erythromycin and had been inoculated 
vvith sensitive strain no. 3055, produced no substance capable of reducing 
growth (Table 8). 
SO/11m I Treatmenl of Celll 10 RelecIJe lntra(e!ll/lt/r Erythl'omyr;naJe. 
Erythromycin solutions which had bem treated witb the solvent-extracted, 
resistant strains of iHicroroul/S pyogmes var. aureus had identical inhibitory 
powers. In each case after treatment by defatted cells of strains no. 3066 and 
no. 3074, dilutions equivalent to an original concentration of 0.39 meg/Illl 
erythromycin inhibited the growth of sensitive strain no. 30.5.5 of M. pyo­
genes var. allreus; dilutions e<.)uivalent to an original concentration of 0.10 
mcg/ml did not inhibit the growth (Table 9). 
Physical Destrt/elioll of Ce!1 J.J'/aLi to Relertse IlltrclcelltJlar Erythromy­
cjl1rtJe. Dilutions of erythromycin which had been treated with alumina 
ground celts of resistant strains no. 3066 and no. 3074 of MicrocotcttJ pyo­
genes var. ourem and the resistant organisms ProteuJ lJUlgal"lJ and Psell­
domollrtJ cl(jrt./ginosa and had been subsequently sterilized retained much 
erythromycin activity. In all four cases dilutions equivalent to 1.2 mcg/ml 
original erythromycin content inhibited growth of the seusitive strain no. 
30.5 5 of M. pyogeJles var. allretlSi dilutions equivalent to 0.4 lTIcg/ml original 
erythromycin content did not inhibit growth (Table 10). 
The Effect of Erylhromycin 017 Ihe Action of Coagulase and other EnzymeJ 
In the preliminary test the presence of coagulase was varied when erythro­
mycin and several erythromycin degradation compounds had been added to 
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the growing organism iHicrOfOUliS pyogenes var. ti/lre1l5. Using str,lin no. 
3055, the control with no compound added, cultures grown with 1 mg/ml 
desosamine,l mg/ml erythralosamine and 1 mg/ml dihydroerl'thronolide aJl 
gave a coagulation value of 4 after 60 minutes. The addition of 100 mcg 
erythromycin at the time of the test reduced the coagulation value of no. 3055 
to 3 at 100 minutes. Using strain no. 3066, the control gave a coagulation 
o
value of 3 at 60 minutes and the addition of 100 mcg erythromycin at the 
J.
time of test reduced the coagulation value to 1 at 60 minutes. 
tl 
In the SEcond series of tests, using suspensions of M. pyogl!lles var. tltlrellf tl 
which had been standardized by a spectrophotometer, the addition of 100 
a 
mcg erythromycin to the mixture of plasma and suspension of organisms at S 
the time of test increased the time reCjuired for coagulation. The six suspen­
e 
sions of the organism coagulated the plasma in pe(iods of time varying from 
40 to 80 minutes. When 100 mcg erythromycin was added at the time of the " 
H 
test, the time required for coagulation was 80 minutes to greater than 3 hours. tl 
The increase in time to bring about coagulation due to the addition of g
erythromycin at the time of the test varied from 40 minutes to greater than 
140 minutes (Table 11) . 
a< 
A third test, with all four strains of Ilf. p}ogeneJ var. aliretlS. revealed cc 
that amounts of erythromycin as small as 0.1 mcg increased the time of co­ ar 
agulation. With all four strains the addition of 1 mcg erythromycin resulted fe 
in still further increases of time required for coagulation. Amounts of ac 
erythromycin in excess of 1 mcg, namely 10 and 100 mcg, did not further sc 
increase time required for coagulation under test conditions but took longer el 
for coagulation thiln those tubes which received 0 or 0.1 mcg of the anti­ g; 
biotic (Table 12). 
It was found that the addition of 100 mcg/ml erythromycin increased cc 
the growth for resistant strains no. 3066 and no. 3074 of JH. pyogeuer var. as 
attl'euJ as measured in percentage light transmission from 23 to 20 and 34 to 01 
28, respectively. ki 
In a ftnal test, the effect of several degradation products of erythromycin re 
on the time required for coagulation was found to vary among the same four di 
strains of M. pyogenl!s vac. at/rells. The average time required for formation ar 
of a coagulum, finn enough to allow inverting the tube without loss of the 
plasma, was 82 minutes. The addition of 1000 mcg desosamine reCjuired on pI 
the average 76 minutes; 1000 mcg cladenose, 80 minutes; 100 mcg eryth­ lC 
ralosamine, 97 minutes; 100 mcg dihydroerythronolide, 112 minutes; ancl p) 
1 mcg erythromycin, over 160 minutes (Table 13). ar 
all
"Tes-Tape," the glucose oxidase and horse-radish peroxidase impregnated 
W paper, was not affected in its reaction to glucose by erythromycin. Tape 
previously saturated with erythromycin standard solution reacted to give the to 
same color upon being wet by glucose solution as a control. ce 
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DiSCUSSION 
Screening of CompolllldJ' /0 De/ennine Re·venal of Po/entia/jon of the
 
Ac/iol1 of El}/hromyt"in
 
Nearly one hundred com.pounds were screend for effect on the inhibition 
of growth of MicfOCOCCJlJ p)'ogeneJ vaI. afiretlS and the spores of Bacillus 
slIb/ilis by erythromycin. Solutions of four of these compounds potentiated 
the action of the antibiotic and solutions of nine of the compounds reversed 
the action. The four compounds which had a potentiating effect were purines 
and had been dissolved, using NaOH, with resulting pH's of 9.9 to 10.4. 
Solutions of the nine compounds which had shown reversal of the action of 
erythromycin were all acidic with pH's ranging from 1.7 to 4.0. Since the 
work of Pittenger et a!. (1) and Haight and Finland (2) indicated that an 
increase in pH resulted in increased activity of erythromycin, it appeared 
that both the potentiating and reversing phenomena resulted from the hydro­
gen ion concentration of the solutions screened. 
The neutralization of the solutions of screened compounds which showed 
activity afforded an opporhmity to determine whether the structure alone 
could account for activity. With the four purines, adenine, guanine, uracil 
and xanthine, neutralization would result in their precipitation and, there­
fore, no useful data could be obtained. Solutions of seven of the nine active 
acidic compounds were brought to pH's between 6.2 and 7.0. None of these 
solutions retained the ability after neutralization to reverse the action of 
erythromycin. As a complementary measure, various other organic and inor­
ganic acids were found to reverse the action of.the antibiotic. 
Revival, apparently, presents a similar situation. Only solutions of acid 
compounds brought about revival and they were for the most part the same 
as those which caused reversal. It would appear that the greater proportion 
of the Micl'oCOCCJ.l.i p)'ogelleJ vaI. ali/ellS and Belcilflif subtilis cells had been 
killed by the "bacteriostatic" concentration of erythromycin. The remaining 
resistant bacteria resumed growth afttr the shift to the acid side, by the ad· 
dition of the solution to the paper disk, reduced the effectiveness of the 
antibiotic to below the bacteriostatic level. 
The halo phenomenon was exhibited in both reversal and revival. In 
plates seeded with the spores of Bact/Ius sl./.btilis the diameters of the inner 
zone of inhibition were larger than those of plates seeded with lvficroi"Ocms 
pyogeneJ var. ewre1fJ, The inner zone of inhibition adjacent to the paper disk 
appears to be a toxic effect of a low pH. Since BacilltlJ sub/ili.1" requires more 
alkaline surroundings it follows that the zone would necessarily be larger. 
With an increase in distance from the paper disk one would expect the pH 
to rise to a level where the bacteria were not inhibited and at which the con­
centration of antibiotic present would be reversed and, finally, at a stiIl 
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greater distance the strength of the acid would have been so reduced that 
the organisms would again be inhibited by the antibiotic. 
It had been suspected that the sulfhydryl radical of cysteine or the closely 
related mercaptoethylamine might react with a ketone group in erythromycin 
but there appears to be no reaction. 
Desosamine, the nitrogen containing sugar which is found in numerous 
antibiotics of the erythromycin group, exhibited no activity of any kind. 
The activity of erythromycin is due to other characteristics of the molecule. 
hl1lestigatiOlz of the Rel/enaL by Calrif./.1n Pcmtothendte and Beta-Alanine of 
the Inhibitory Effa!s of Erythromycm Oil Several Species of Bactel'1a 
Very little has been found to support the thesis that Ca-pantothenate and 
beta-alanine act as antagonists of erythromycin. Brown and Emerson (4) 
used Ca-pantothenate and beta-alanine to reverse the inhibition of Corynebac­
te1·i/.t1n diphtheriae by erythromycin. Employing the same medium but using 
different strains of the bacterium, Ca-pantothenate and beta-alanine did not 
reverse the action of erythromycin. In this study ratios of Ca-pantothenate 
and beta-alanine to the antibiotic equalled or smpassed those used by Brown 
and Emerson. The data reported here do not confirm their findings, although 
other strains were used. 
\'{forking with other organisms and V<lrious technics, indications of the 
reversal of tbe action of erythromycin by Ca-pantothenate or beta-alanine 
were found in two instances. The "Gebriider Mayer" strain of Sarrharomyces 
rerevisiae showed reversal of inhibition due to the antibiotic in the presence 
of both Ca-pantothenate and beta-alanine. The reversal of erythr,Omycin 
was seen at only one inhibitory concentration of the antibiotic since higher 
levels were not practical due to its limited solubility. Therefore the nature of 
the reversal cannot be determined. Two alternative explanations of the re­
sults can be made. Since the yeast requires either Ca-pantothenate or beta­
alanine, the antibiotic cannot be inhibiting the growth and di vision by block­
ing the production of Ca-pantothenate or beta-alanine. It is possible, 
however, that the erythromycin acts by competing with Ca-pantothenate or 
beta-alanine for a position in an essential enzyme system. As an alternative, 
erythromycin could be interfering with an essential enzyme system which is 
distinct from the enzyme system in which Ca-pantothenate and beta-alanine 
play an iruportant role. In this situation the addition of a sub-bacteriostatic 
amount of erythromycin and the presence of a low amount of Ca-pantothe­
nate would interfere with the normal operation of the respective enzyme 
systems. While the reduced action of either enzyme system alone would not 
prevent growth and reproduction, the reduced action of both enzyme sys­
tems would, synergistically, inhibit growth or reproduction. If the reversal 
is competitive_ it may be estimated that either 0.02 mcg Ca-pantothenate,or 
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1 mcg beta·alanine reverse the action of 100 mcg erythromycin. The activity 
coefficients of Ca· pantothenate and beta-alanine would be 5,000 and 100, 
respectively. LactobacillNs c,Hei showed no reversal of the action of the anti· 
biotic with beta-alanine; but in the presence of the minimal inhibiting con· 
centration of erythromycin, the bacterium showed an apparently non·com." 
petitive reversal of the inhibition by Ca· pantothenate. 
In the other organ isms studied, Ca-pantothenate and beta·alanine did not 
re-verse the inhibitory action of erythromycin. The inhibition by erythromy­
cin of Diploco((IIJ pneumoniae, j\1irroco((uS p)'ogenes var. al./.rellS! and 
SlreptoCO({IIS pyogeneJ was not reversed by Ca·pantothenate at concentra­
tions as high as 10 mcg/ml or beta-alanine at concentrations as high as 1000 
mcg/m!. The average level of pantothenic acid in human blood was found 
by Pearson (47) to be 0.19 mcg/ml. It appears unlikely that vitamin therapy 
would increase the pantothenic acid above blood levels at which no reversal 
of the action of erythromycin would occur. 
If the action of erythromycin were reversed by Ca-pantothenate, resistance 
of organisms might be due to synthesis of large amounts of that vitamin. 
Amounts of pantothenic acid produced by two highly resistant strains of 
AIicTo(O(c/./J pyogenes var. elm'eNS were almost equal to that produced by a 
sensitive strain. The enzyme mylase made pantothenic acid in a bound form 
available for assay. These data are convincing in showing the lack of any C0111­
petitive relationship between erythromycin and pantothenic acid. Since 
beta-alanine is a precursor of pantothen ic acid (48), the above data consti­
tute indirect evidence that synthesis of beta-alanine is not the means by which 
these strains are resistant to the antibiotic. 
The evidence that the resistant strains of lYli(l'OCOCCllS p)/ogeneJ var. aurem 
and the two organisms, PrOleus [!ltIge/ris and Pseudomonas cterNgilwsc/! do 
not produce extracellular erythromycinase, is equally valid as evidence that 
they do not produce extracellular metabolites competitive with erythromycin. 
With the possible exception of data found using the "Gebriider Mayer" 
strain of Sacrhm'omyreJ cerevisiae. all results indicated that neither Ca· pan­
tothenate or beta-alanine competitively reversed inhibition caused by erythro­
myCI11. 
In·lJestigation of tbe Presence of Intracellll/m' etlld Ex/rC/(elllllcrr
 
Er),thromycillclJe
 
One mechanism which might account for the resistance of certain strains 
and organisms to erythromycin would be the presence of erythromycinase. 
The enzyme might be present either in an extracellular form Or in an intra· 
cellular form. 
Neither of the two resistant iHiao(Occtls pyogelles var. cUlteNJ strains nor 
ProtellJ vlIlgariJ nor PsetrdomonclJ aeruginoJC/ reversed the inhibition of the 
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two sensitive seed organisms by erythromycin. In addition, resistant strains mine, dl 
of iH. pyogenes var. am'eNS were grown in dialyzing tubes surrounded by compare 
media containing erythromycin. It should be expected that the erythromycin activity 
would diffuse through the cellophane tube to the organisms and be broken ponentl
down if erythromycinase were present. Here again there was no indication 
W.lS not 
of destruction. tests of 
It should be noted that if apparent destruction of the antibiotic had oc­ erythror 
curred it would be necessary to determine whether erythromycinase had I11l11e, e[ 
destroyed the erythromycin or a competitive metabolite had been produced. One, 
Since no extracellular eryt.hromycinase was found, it can be concluded of Micr 
that the resistant strains of /\tIicrocOCClIJ pyogem,s var. aureus are truly re­ of the r 
sistant. It had been found previously that some "resistant" organisms pro· the org; 
duce an antibiotic destroying enzyme which changes the environment by 
noted, ~ 
reducing the antibiotic concentration below the threshold level so that the in the F 
truly sensitive organism can grow. Such is not the case here. 
coagula
The possibility of an intracellular erythromycinase still remained. The It wc 
treatment of cells by fat solvents has been found to render the walls of the in vivo 
cells permeable enabling molecules as large as penicillin, for example, to fact th< 
come in contact with enzymes in cells (4). There was no evidence, however, phenorr
of erythromycinase in the solvent-treated strains studied. The use of high 
counter 
freguency sound waves to break down the cell walls was rejected because the <lgu)ase 
ceJJs of iHicrococclfS pyogel1es var. allreus offer great resistance to this treat­
organls 
ment. Confirmation by grinding with alundum was chosen since it is ef­
would, 
fective and yet causes a minimum of denaturation of the protein of the cell. in-vivo· 
Apparently there was some absorption of the antibiotic on the alundum and tion of 
the contents of the cells; but the amount of erythromycin left free in the 
more Ii 
solution after treatment was still many times that necessary to inhibit the biotic \ 
growth of a sensitive strain. Thus, the evidence is strong that intracellular 
other n 
erythromycinase is not present in the two resistant strains of M. pyogeneJ 
conneel 
var. tltfretiS and in Proteus vulgaris and Pseudomonas aeruginosa.· The 
No evidence of either extracellular or intracellular erythromycinase was 
screel1l. 
found in the organisms studied. pyogen 
which 
The Effect of Erythromycin on the Action of Coagulase and Olhel' Enzymes	 clinical 
geller'
Originally it had been suspected that the effectiveness of eryt}uomycin 
in vivo in mjce against strains of MiCI'OCOUIIJ pyogenes var. aurefls was due 
to an effect on coagulase by erythromycin. This matter was pursued when 
Boniece et al. (34) revealed that erythromycin in small amounts reduced the Eryt
activjty of coagulase. From the results obtained using four strains of Micro­
of one (OCCUS pyogeneJ var. aureus there is no doubt as to the reduction of the speed A S( 
of coagulase activity when small amounts of erythromycin were added at the geiles'
time of test. Furthermore, the degradation compounds, c1adenose, desosa· 
clpabl 
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unts of erythromycin were added at the 
adation compounds, c1adenose, desosa­
mine, dihydroerythronolide, and erythralosamine, had little if any activity 
compared with erythromycin. It appears that the property of redUCIng the 
activity of coagulase is evanescent as the antibiotic is cleaved IOtO Its COIn­
ponent parts. The data concerning dihydroerythronolide and erythralosamlOe 
was not statistically significant and it would be worth while to make furthe~ 
tests of the effect of these compounds on coagulase. The inhibitory action ok 
erythromycin cannot be associated with its degradation compounds; desosa­
mine, erythralosamine, and dihydroerythronolide. . 
One conclusion is obvious, erythromycin interferes with sensitive strains 
of MicroCO((IIS pyogener var. am·ens in at least two ways: it inhibits portions 
of the metabolic system which function in the growth and reproduction of 
the organism; and it interferes with the action of coagulase. It should be 
noted, however, that cOtlgulase was still formed by resIstant stralOs growmg 
in the presence of the antibiotic. Erythromycin interferes with the action of 
coagulase not with its production, . 
It would appear that with the finding of an antibiotic which protects mice 
in vivo against in vitro resistant iHicro(ocO.lJ pyogmes vaL atlretlS, and the 
LKt that the antibiotic reduces coagulase activity, one may have found a 
phenomenon of considerable utility. Let it be assumed that erythromycin 
counteracts /11. pyogeJle5 var. rl1lfetlS in vivo by reducing the speed ot co­
agulase activity. Since the antibiotic does not inhibit the reproduction of the 
organism, but inhibits the actioCl of one of its enzymes acting externally, Jt 
would appear that there would be little tendency for the development of an 
in-vivo-fast strain which would produce a coagulase more reSistant to the ac· 
tion of erythromycin. Since this is a most versatile organism, it would appear 
more likely that the protection afforded to the animal by the use of the anti­
biotic would favor the development of strains which might be resistant to 
other Il.ltural host defenses and might kill the host by a method in no way 
connected with the coagulase action. 
The effect on the speed of coagulase activity may be an in vitro inde>: for 
screening drugs and antibiotics for in vivo effectiveness against i~fiCl'oco([tI.r 
pyogelles var. LlIII·em. The finding of active substa.nces by thIS 10 vltr~ method 
which would be also active in vivo, would, aSIde from the pOSSibility of 
clinical usefulness, throw additional light on the manner in which M. pyo­
gei/es var. LltlreUf behaves in vivo. 
CONCLUSION 
Erythromycin is antibiotic by its interference with the normal funttioning 
of one or more enzyme systems in sllsce?tible organisms. 
A s<.reening of nearly one hundred compounds, using /l,fjcroco~Cf.lJ pyo­
f!.elleJ var. t/l.tl·eus and the spores of Bacilftls sub!ilif; revealed no substances 
~:lpable of reversing the inhibition caused by erythromycin. Compounds in 
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re(O;~lm.cr
aCId solution acted to reverse the activity of errthromrtin and (ompound~ 
effecti \TIlIin alkaline solution acted to poteMiate its activity; but the basic tause was 
The in;the acidity or alkalinity of the solution. 
. inability lFor clinical purposes, the revival of organisms lI1hibited by erythromycin 
nU'~1erous
would appear to be favored by planting into media with as Iowa pH as would 
mycinase,be compatible with the orgaf\ism. 
mode of ; No evidence was found that Ca-pantothenate or beta-alanine reversed 
on the va
competitively the inhibition by erythrOf\lycin of CorynebacterillllJ diphthe­
enzyme s:
rial!. Diplocor({fs p"el/II/oniae. uictobdcillllr uuei. MicrococCI!J pJ'ogmec 
var. C1llFellS and Strepto(OCWC pyogel/es. 
Both Ca-pantothenate and beta·alanine brought about reversal of the 
inhibition of S(/uhar(}177Y<'e' cerell/jirle by erythromycin. Owing to solubility 
limitations it was not possible to use larger amounts of the antibiotic and SlOcen 
determine the presence of a competitive reversal of the type exhibited by versity fc 
p-aminobenzoic "cid and the sulfa drugs over large variations of concentra­ of this m 
tion. gestiof\s ( 
No evideme was found of the synthesis of a metabolite comf)etitive with whose (01 
erythromycin by re,istant organisms. Resistant straillS of i'vl;ao(o£'('11.I pyo­ With ref!, I 
gt1zes var. allreliS synthesized the same amount of pantothenic atid as <I sen­ student a 
sitive strain. Gats' test demonstrated that resistant strains of ;H. pyogenl!' Thanks i 
\ar. tiliretl\' Protem !'lilgrll'lf, :lnd P1emlomolltJs aertlglflOf(/ synthesized no of certair 
extracellular metabolite capable of reversing the action- of erythromycin. 
Neither eJ'tracellular nor intracellular erythromycin,lse was found in i\'(/­
l1'OCO(OIS pyogeJles var. ,.lIIre"f. P"otellJ IllIlgar;J. or Pll!lIdomo!l(/s rtemgillosa. 
Neither solvent treatment nor mechanical rupcuring of cells released such an 
cnzyme. 
Desosamlne, " structure common to numcrous members of the erythromy­
EfCecr of (
cin 'lntibjotic group, has no effect on the action of erythromyci n and Ius no 
bacteriostatic effect on iHicroco(CIIS pyogeneJ var. CinreltS or on the spores of 
Br/rillll f .f1Ibtills. 
The finding of Boniece et al. (34) that erythromycin reduced the activity 
Calc
of the coagulase of il,firrocou/lJ pyogelll!r var. tltlreus was confirmed. Desosa­ PaD! 
[hcnmine and c1adcnose, degradatjon products of erythromycin, did not reduce 
meg.
the activity of coagulase. It is suggested that additional work should be done 
oto determine whether the reduction of activity of coagulnse by dihydro­
o
erythronolide and erythralos'lmine is significant. None of the four degrada. o 
tion products of erythromycin tested had an effect on coagulase whith 2 
approached that of the antibiotic. 20 
Erythromycin had no effect on the emymes glucose oxidase and horse­
radish peroxidase. 
It is suggested that in view of erythromycin's reduction of the activity of 
coagulase, there may be little tendency for "in vivo resistant" strains of A(i­
rrorocC!/j pyogmeJ var. d1l1'etlJ to develop. The coagulase activity test is 
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(/obt/o!!1IS ctlJei. !'vf icrococOfl pyo<~eller 
'/7e.f. 
-alanine brought about reversal of the 
ioe by erythromycin. Owing to solubility 
se larger amounts of the aotibiotic and 
iti"e reyersal of !he type exhibited by 
drugs o\'cr large variations of conc entra­
·nthesis of a metabolite competitive with 
s. RcsistlOt strains of Mmococrtlf Pyo­
me amount of pantothenic acid as a sen­
cd that resistant strains of M. pyogmes 
PJellt!o/JilliJaJ aeft/gmora synthesized no 
re\"Cfsinl-' the action of erythromycin. 
lulu crythrom)'cinase was found in ,lfi­
~1J.r l'ldgtiris, Or PJet/do7llollaJ aemgillosa. 
:mical rupturing of cells released such ao 
to num(;rous members of the erythr0111)'­
n the ,lction of erythromycin and h1.s no 
pyogeill::.r \·ar. cillretli or on the spores of 
) that erythromycio reduced the activity 
geller vaL ,l1Iret/J was confll·111ed. Desosa­
roducls of erythromycin, did not reduce 
ted that additional work should be done 
n of activity of coaguhlse by dihydro­
IS significant. None of the four degrada­
t.cd had w (;fft:ct on cO:lgulase which 
the enzymes glucose oxidase and horse­
romycin's reduction of the activity of 
q' for "in vivo resistant" strains of MI­
de\·c!0p. The coagulase activity test is 
recommended ciS an in virro method for the testing of drugs for their in vivo 
effectiveness against Ai. pyogel7es var. clt/rellS. 
The inactivity of variollS metabolites on the action oi erythromycin, the 
inability of Ca-pantothenate and beta-alanine to reverse the inhibition of. 
nU!;leroUS organisms by the antibiotic, and the apparent absence of erythro­
mycinase, lead to the conjecture that the 1110st fruitful areas of study of the 
mode of action would be: 1. the investigation of the effect of erythromycin 
on the various enzyme systems in the bacterial cell; 2. the comparison of th? 
enzyme systems of sensitive and resistant strains of the same organism. 
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TABLE 
Effen of CalCium Panwchenate and Erythromycin on the Hydrogen Ion Concentration 
of L!lctob!ld/l"J casn 
erythromycin rncglml 
Calcium 0.0 0.04 0.2 l.0 
PaOlO­
cnenale pH pH pH DH 
mcg/ml 
0.0 5.) 5.5 ).B 6.5 
002 44 4.5 51 6.4 
02 4.1 4.1 4.6 6.4 
2.0 4.1 11.2 4.8 6.4 
20.0 41 41 4.8 6.4 
TABLE 2 
Efte( 
ECfecl of Bela·Alanine and ErylhlOmycin of lhe Hydrogen Ion Concenlrarion of 
LtfClobtf{j/l1l.i Ctfsej 
erylhromyein meg/ml 
Bela' 0.0 O.Z 2.0 20.0 
AJanine
 
mcg/ml pH pH pH pH
 
0.0 4.1 4.7 6.' 6.7 
0.2 4.2 4.6 6.7 6.7 
2.0 4.1 4.7 6.7 6.7 
20.0 4.2 4.7 6.7 6.7 
200.0 4.1 4.6 6.7 6.7 
TABLE ;, 
Elfect of Calcium Pantotbenate and Erythromycin 
on the Growth of "Gebriidcr Mayer"' Strain 
of S(/ah"romjcer celetJIsi<le 
erYlhromycin meg/ml 
Calcium 0 10 
Panto· 
rhen(ue (readings in opcical densil.v) 
meg-lOll 
0.000 .014 .016 .OL5 
0.005 .081 07;' .012 
am .092 .095 ,080 
0.02 .121 .116 .122 
0.03 . L27 .122 .126 
0.04 .1;,4 .128 .134 
0.05 .140 136 . I;' 7 
206 
100 
.OLO 
.044 
.055 
.078 
.t02 
.123 
.129 
Efr 
Be 
At 
m< 
• I 
val 
E 2 
of the Hydrogen Ion Concentration of 
1uJ CtlJ't'i 
In rncg:'ml 
2.0 20.0 
pH pH 
., 6.7 6.7
 
.6 6.7 6.7
 
6.7 6.7 
6.7 6.7 
6.7 6.7 
LE 3 
hen ate and Erythromycin 
bruder !\"fuyer" Strain 
ceJ fC'J'e'rhi:le 
in mq:/ml 
10 lOa 
adiogs in OPtical densio.. ) 
.oL6 .015 .0lD 
.073 .072 .044 
.095 .080 .055 
.116 .122 .078 
.122 .126 .102 
.128 .134 .123 
.136 .137 .129 
TABLE 4 
EHc('t of Beta-Alanine and Erythromycin On the Growth of "Gebrudec Mayer" Strain 
of Sacc!Jll101/1 yces ..-et·e·vi5iae 
erythromycin mcg/enl 
Bela. a 10 100 
Alanine 
mcg/ml (readings in Optical density) 
0.0 024 .009 .004 .003 
0.2 .1l6 .135 054 
0.4 .216 .211 .195 .126 
0.8 .242 .266 .264 .224 
1.6 .276 .290 .274 .276 
3.2 .300 .294 .296 .282 
TABLE 5 
Effen of Beta-Alanine and Calcium Pantothenate on the Growth* of M ;c)"OCO""'5 
P)'lif!.tI1fJ var. allrellS, Strains no. 3055 and 3067. 
erythromycin mcg/ml 
Str.in no. 3055 Strain nO. 3067 
Calcium 0.0 0.1 0.2 0.5 l.0 0·0 0.1 0.2 0.5 l.0 
Pao£othen:ue 
meg-/ml 
0.0 <i 4 4 0 0 4 .-I 4 0 0 
O.L 4 <I <i <i 0 4 if 4 0 0 
1.0 4 4 4 0 0 4 4 4 0 a 
10.0 4 4 4 0 0 4 4 4 0 () 
Beta 
Alanine 
mcg/ml 
0 4 4 .-I 0 0 <I <I 4 0 a 
10 4 4 4 0 0 4 4 4 0 0 
100 4 4 0 0 4 4 4 0 0" 
1000 4 <I 4 0 0 4 4 4 0 0 
Growth was determined bv visuaL estimate of lurbidity. Very heavy growth was given a 
vahle of 4; hea\'Y growlh~ 3; moderate growth, 2; slight growth. 1; and no growth. 0, 
Dilu 
from 
Ing I 
• Gr< 
value 
Gem 
nn 
TABLE G 
EFfecr of Bera·AJanine and Calcium Pancorhenate on d,e Grow,h* of D,plr"wm, 
pnemno"iae Park I and StreploCQcCII.' pyn¥"Jld C203 
D. !U]eI(J!lfj"iat S. py()gelle~ 
erylhromycin mcgjmL 
.000 .005 .010 .020 .040 .000 .005 .010 .020 .040 
Ca-PaOlo. 
theoale 
mcg/ml 
0.0 4 2 0 0 0 4 2 2 0 0 
0.1 2 0 0 0 4 2 2 0 0
"
 1.0 4 2 0 0 0 4 2 2 0 0 
10.0 4 2 0 0 0 4 2 2 0 0 
Bera· 
Alanine 
m,g/ml 
0 4 2 0 0 0 4 2 0 0 0 
]0 4 2 0 0 0 4. 2 0 0 0 
100 4 2 0 0 0 4. 2 2 0 0 
1000 4 2 0 0 0 4 2 2 0 0 
Growth was determjned by visual es(im,\Ie of turbidj(y. Very heavy growth was given a 
vaJue of 4; heavy growth) 3; moderale gcowth, 2; slight growlh, l ~ and no growtb, O. 
TABLE 7 
Effec' of Beca-Alanine and Calcium Pancothenate on rhe Growrh* of Corynelutcf.eri"", 
diphlheriae 
SIr.in x- ~ 66 Strain Toronto 
ery,bromydo meg/ml 
Ca-PaOlo­
rhenare 
meg/mJ 
.000 .004 .008 .016 .032 .000 .004 .008 .016 .032 EQuiv 
Prese 
0.0 
0.1 
1.0 
10.0 
4 
4 
4 
4 
4 
<1 
4 
4 
3 
3 
3 
4 
2 
2 
2 
4 
4 
4 
4 
" 
4 
4 
4 
4 
3 
3 
3 
4 
2 
2 
2 
4 
Be,.-
Alaoioe 
, Gte 
meg/ml value 
0 4 4. 3 2 1 4 4 3 2 
10 4 4 3 2 1 4. 4 3 2 
100 4 4 3 2 1 4 4 3 2 
1000 4 4 3 2 1 4 4 3 2 
.. Growth was dere(mined by ,'isual esrima[e of turbidity. Veo' beav.v growth was given a 
value of 4; heavy grow,b. 3; moderate grow,h, 2; slight growth, l; and no growth, O. 
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.040 
TABLE 8 
ammhenme on rhe Growrh * of Dipl{)<."Ocof' Gwwrh * of M IcrOCOLW'< p)'Ogme.< var. attrtitJ in rbe Presence of Dllurions of Eryrhromy. 
S"·ep/[)(&WI.r pyogmn C203 Cln Treared by Con mer IVlrh Dialyzing Tubes Seeded wirh ReSlsranr Smllns of M. 
o 
o 
o 
o 
0 
0 
0 
0 
5. P)'Ogenei jJ)'oge1UJ val. ,lIIreu.l 
Not Inocu- SLraill 5rrain Strain 
.000 .005 .010 .OZO .040 laced no. 3066 no.3074 no. 3055 erylhromycin mcg/ml (originill COrlCenrc31jon) 
Dilution of medium 
from ourside of d'alyz­ 100 100 100 0 
ing rubes 
4 
4 
4 
4 
2 
2 
2 
2 
2 
2 
2 
2 
0 
0 
0 
0 
o 
o 
o 
o 
1 
1 
1 
1 
2 
4 
8 
16 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
4 
4 
4 
4 
1 32 0 0 0 4 
1 64 0 0 0 4 
~ Growth was determined by visual csdmare of turbidity. Vee}' heavy growth was ghen i\ 
:j 2 0 0 0 value of 4; heavy growlb, 3; moderare growrh. 2; slight grow(h. 1; and no growth, O. 
4 2 0 0 0 
4 2 2 0 0 
4 2 2 0 0 
e of turbidity. Ver)' heavy growth was gi"en a 
• 2; slj~ht growrh, 1; and no grow lb. O. 
LE 7 
odlenate on rhe Growrh * of Coryml}(lCfaillm TABLE 9 
tho'i"f 
Growrh* of MicrocoutiS pyogmcs val. a"reuJ in rhe Presence of Dilutions of Eryrhromy· 
cin Treared by Solvenr·Exrracred Resisram Strains of M. pyogene.' val. aureltJ 
Strain Toronto 
ythrom)"cin ntcgjrnl 
.032 .000 .004 .008 .016 .032 Equivalenl of ErYlhromycin Originally Strain Strain 
PreseQ( afler Dilurion meg/ml Control no. 3066 no. 3074 
100.00 0 0 0 
2~.OO 0 0 0 
4 4 3 2 1 6.25 0 0 () 
4 4 3 2 1 1.56 0 0 0 
4 4 3 2 1 0.39 0 0 0 
.~ 4 4 4 1 O.lO 4 4 4 
0.00 4 4 4 
a Growch was determined by visual estimate of curbidjty. Very be~n'Y growth was given a 
value of 4; heaYy growth, ~; moderate growth. 2; slight growth, 1; and no growrh, O. 
1 'i 4 3 2
 
1 4 4 3 2
 
1 4 4 3 2
 
1 4 4 3 2
 
of lurbidjt),. Yen' heav,:, growth was given a
 
.2; slight growth, 1; and no growth~ O.
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TABLE 10 
Effecr ofGrowth" of ilyficrococClis p)'ogenes var. allTeIl! in the Presence of Dilurions of Eryrhro­
mycin Treated by rhe Ruprured cells of Four Banerjal Srrains 
Strain noEQuivaleot of Ery[hromy. i\(i,cro(:oc:clls pyogeues- ProteffJ P5eudomOfldJ 
cin OdginaHy Presenr var. 411relt$ IlIflgariJ aerllginord 
after Dilution Slcain Stcain Erythron 
mcgJml no. 3066 no. 3074 of test n 
11.0 0 0 0 0 
3.7 0 0 0 0 
1.2 0 0 0 0 
0.4 4 4 4 4 
0.13 4 4 4 4 
0.0 4 4 4 '( 
" Growtb was determined by a visual estimate of turbidity. Very heavy growth was given a 
value or 4: hea\'y 8ro"CV[h, 3; moderale growth) 2; sligh( growth, 1; and nO growth. O. 
ETABLE 11 
Effecr of Eryrhromycin on rhe Coagulation of Plasma by ,\1.j'TOCOCClIJ p)'ogene.< var. 
Strain n( 
,u,rellS 
Compo 
Erythromycin dueing gcowlh o o lOa o o lOO at (In 
mcg!ml 
Straio no. 3055 3066 3066 3067 3074 3074 
None, I 
Eryrbromycin added at 
rime of lesr meg/ml minutes required for coagulation 
0 '(0 40 40 50 80 50 
100 80 over 130 140 180 180 
180 
Increase in time due ro 40 over 90 90 100 130 
erythromycin 140 
210 
Desosa 
meg. 
Cladenl 
meg 
Eryrhta 
100 J 
Dihydr 
100 I 
Eryrhrc 
I me 
TABLE 12ABLE 10 
Effecr of Different Concenrrarions of Eryrhromycin on rhe Coagularion of Plasma by 
ured cells of Four Bacterial Strains 
reUJ in the Presence of Dilutions of Eryrhro· 
Mic1'OfOCCII.r p)'ogt'lZe.r var. aurellj 
S(cain 00. 3055 3066 3067 3074ProJeus P ..eltdonroJuJJ 
4Nrtlls v"lgaris aerJlgi"05Q 
SCnlio Eryrhrornycin added at rime 
no. 3074 
of resr mcg/ml minures required for coagularion 
() 0 0 0 30 40 40 )00 0 0 
ABLE 11 
'mare of [urbidiry. Very heayy growlh was gi\len a 
""h, 2; sligh' grow,h, I; and 00 grow'h. O. 
211 
TABLE 13 
Effect of Degradarion Products of Erythrornycin on the Coagularion of 
Plasma by Mi"rocoeem pyogenes vaL al/reltJ 
Sc,Calll 00. 3055 3066 3067 3074 
Compound added 
ar rime of test. minutes required for coagulation 
None, control ... 30 70 130 100 
Desosamine. 1000 
mcg. 40 60 100 100 
CJadenose, 1000 
mcg )0 70 100 100 
Erythralosamine, 
100 mcg. 60 70 130 130 
Dihydroeryrhronolide 
100 mcg. 60 130 130 130 
Erythromycin, 
1 mcg. 100 over 180 over L80 Over 180 
0.1 40 60 80 70 
70 130 150 over 180 
10 70 130 100 130 
100 70 90 90 100 
3074 
100 
3074 
o 
3067 
o 
3066 
100 
210 
3066 
o 
s required for coagularion 
40 40 )0 80 )0 
over 130 140 L80 L80 
180 
over 90 90 100 130 
140 
0 0 0 
4 4 4 
4 4 4 
4 4 4 
ularion of Pbsma by MitrocorCIIJ p)'ogemJ vaL 
tlllrPIIJ 
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